Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 1;119(7):1402-11.
doi: 10.1002/cncr.27795. Epub 2013 Jan 28.

Survival After Lumpectomy and Mastectomy for Early Stage Invasive Breast Cancer: The Effect of Age and Hormone Receptor Status

Affiliations
Free PMC article

Survival After Lumpectomy and Mastectomy for Early Stage Invasive Breast Cancer: The Effect of Age and Hormone Receptor Status

E Shelley Hwang et al. Cancer. .
Free PMC article

Abstract

Background: Randomized clinical trials (RCT) have demonstrated equivalent survival for breast-conserving therapy with radiation (BCT) and mastectomy for early-stage breast cancer. A large, population-based series of women who underwent BCT or mastectomy was studied to observe whether outcomes of RCT were achieved in the general population, and whether survival differed by surgery type when stratified by age and hormone receptor (HR) status.

Methods: Information was obtained regarding all women diagnosed in the state of California with stage I or II breast cancer between 1990 and 2004, who were treated with either BCT or mastectomy and followed for vital status through December 2009. Cox proportional hazards modeling was used to compare overall survival (OS) and disease-specific survival (DSS) between BCT and mastectomy groups. Analyses were stratified by age group (< 50 years and ≥ 50 years) and tumor HR status.

Results: A total of 112,154 women fulfilled eligibility criteria. Women undergoing BCT had improved OS and DSS compared with women with mastectomy (adjusted hazard ratio for OS entire cohort = 0.81, 95% confidence interval [CI] = 0.80-0.83). The DSS benefit with BCT compared with mastectomy was greater among women age ≥ 50 with HR-positive disease (hazard ratio = 0.86, 95% CI = 0.82-0.91) than among women age < 50 with HR-negative disease (hazard ratio = 0.88, 95% CI = 0.79-0.98); however, this trend was seen among all subgroups analyzed.

Conclusions: Among patients with early stage breast cancer, BCT was associated with improved DSS. These data provide confidence that BCT remains an effective alternative to mastectomy for early stage disease regardless of age or HR status.

Figures

Figure 1
Figure 1
The Impact of Tumor Size and Age at Diagnosis on rate of BCT in women with stage I or II breast cancer, 1990–2004
Figure 2
Figure 2
A. Kaplan-Meier Overall Survival estimates for HR-negative patients, age <50 years at diagnosis: comparison of BCT and mastectomy groups. B. Kaplan-Meier Overall Survival estimates for HR-positive patients, age ≥ 50 years at diagnosis: comparison of BCT and mastectomy groups.
Figure 2
Figure 2
A. Kaplan-Meier Overall Survival estimates for HR-negative patients, age <50 years at diagnosis: comparison of BCT and mastectomy groups. B. Kaplan-Meier Overall Survival estimates for HR-positive patients, age ≥ 50 years at diagnosis: comparison of BCT and mastectomy groups.

Comment in

Similar articles

See all similar articles

Cited by 44 articles

See all "Cited by" articles

Publication types

Feedback